Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("AOGI, K")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 16 of 16

  • Page / 1
Export

Selection :

  • and

Intra-arterial chemolipiodol therapy with low dose CDDP-lipiodol suspension for unresectable liver cancerAOGI, K; SAWAMURA, A; YAMAGUCHI, Y et al.Regional cancer treatment. 1996, Vol 9, Num 2, pp 83-87, issn 0935-0411Article

A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapySEGAWA, Y; AOGI, K; INOUE, K et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1874-1880, issn 0923-7534, 7 p.Article

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil―epirubicin―cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapyOHNO, S; CHOW, L. W. C; NAKAYAMA, T et al.Breast cancer research and treatment. 2013, Vol 142, Num 1, pp 69-80, issn 0167-6806, 12 p.Article

Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)KATSUMATA, N; WATANABE, T; TAKASHIMA, S et al.Annals of oncology. 2009, Vol 20, Num 7, pp 1210-1215, issn 0923-7534, 6 p.Article

Introduction of Gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosisKIM, R; OHI, Y; INOUE, H et al.Anticancer research. 1999, Vol 19, Num 3A, pp 1779-1783, issn 0250-7005Article

Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potentialAOGI, K; NISHIYAMA, M; KUSANO, T et al.International journal of cancer. 1997, Vol 72, Num 2, pp 295-300, issn 0020-7136Article

Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells : differences in in vitro and in vivo systemsNISHIYAMA, M; SAEKI, S; AOGI, K et al.International journal of cancer. 1993, Vol 53, Num 6, pp 1013-1016, issn 0020-7136Article

A role for plasma membrane potential in doxorubicin-induced cytotoxicityNISHIYAMA, M; AOGI, K; SAEKI, S et al.Anticancer research. 1992, Vol 12, Num 3, pp 849-852, issn 0250-7005Article

FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancerTAMURA, K; SHIMIZU, C; KOIZUMI, F et al.Annals of oncology. 2011, Vol 22, Num 6, pp 1302-1307, issn 0923-7534, 6 p.Article

Telomerase activity in lesions of the thyroid : Application to diagnosis of clinical samples including fine-needle aspiratesAOGI, K; KITAHARA, K; BULEY, I et al.Clinical cancer research. 1998, Vol 4, Num 8, pp 1965-1970, issn 1078-0432Article

A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancerAOGI, K; IWATA, H; MASUDA, N et al.Annals of oncology. 2012, Vol 23, Num 6, pp 1441-1448, issn 0923-7534, 8 p.Article

Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution surveyKAWAGUCHI, K; ISHIGURO, H; MORITA, S et al.Breast cancer research and treatment. 2011, Vol 130, Num 2, pp 627-634, issn 0167-6806, 8 p.Article

Evaluation of the safety and tolerability of oral TAS-108 in postmenopausal patients with metastatic breast cancerSAEKI, T; NOGUCHI, S; AOGI, K et al.Annals of oncology. 2009, Vol 20, Num 5, pp 868-873, issn 0923-7534, 6 p.Article

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studiesTOI, M; IWATA, H; WATANABE, J et al.British journal of cancer. 2009, Vol 101, Num 10, pp 1676-1682, issn 0007-0920, 7 p.Article

Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroidAOGI, K; KITAHARA, K; URQUIDI, V et al.Clinical cancer research. 1999, Vol 5, Num 10, pp 2790-2797, issn 1078-0432Article

Clinical significance of P-glycoprotein expression analyzed by immunohistochemical staining in cancer tissuesKIM, R; HIRABAYASHI, N; NISHIYAMA, M et al.Japanese journal of surgery. 1991, Vol 21, Num 5, pp 590-593, issn 0047-1909Article

  • Page / 1